A compound with the SMILES CCN1CCN(Cc2ccc(NC(=O)c3cc(NC(=O)c4nccnc4N)cc(OC)c3)cc2C(F)(F)F)CC1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 6.979%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCN1CCN(Cc2ccc(NC(=O)c3cc(NC(=O)c4nccnc4N)cc(OC)c3)cc2C(F)(F)F)CC1
CCN1CCN(Cc2ccc(NC(=O)c3cc(NC(=O)c4nccnc4N)cc(OC)c3)cc2C(F)(F)F)CC1
3-amino-N-[3-[[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]-5-methoxyphenyl]pyrazine-2-carboxamide